跳至主要内容
临床试验/CTIS2023-504188-18-00
CTIS2023-504188-18-00招募中1 期

Evaluation of the efficacy of micronized natural progesterone (Seidigestan®) vs GnRH antagonists (Astarté®) in the prevention of LH surge during controlled ovarian stimulation: a randomized clinical trial. - IBMR43

Instituto Bernabeu S.L.0 个研究点目标入组 150 人开始时间: 2023年2月28日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
18 至 64(—)

入选标准

  • Be eligible to enter the Instituto Bernabeu's oocyte donation program., Age between 18 and 33 years, BMI >18 and <30, Antral follicle count >8 (adding both ovaries)., Presence of both ovaries, Ability to participate and comply with the study protocol., Understand Spanish orally and in writing., Have given written consent

排除标准

  • Diagnosis of endometriosis at any stage., Diagnosis of any ovarian tumor whether benign or malignant, Concurrent participation in another study, Malabsorptive syndromes that may alter the efficacy of Utrogestan ® such as bariatric surgery, ulcerative colitis or Crohn's disease., Irregular periods., Hypogonadotropic hypogonadism., Having received in the previous two months treatment with ovulation stimulators., Having previously participated in the present study.

研究者

发起方
Instituto Bernabeu S.L.

相似试验